Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Migraine Headache, With or Without Aura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00387881
What this trial is testing

TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)

Who this might be right for
Migraine, Without Aura
GlaxoSmithKline 679
Large-scale testing (Phase 3)Study completedNCT00122278
What this trial is testing

Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines

Who this might be right for
Migraine
Montefiore Medical Center 205
Large-scale testing (Phase 3)Study completedNCT01004263
What this trial is testing

Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)

Who this might be right for
Acute Migraine With or Without Aura in Adolescents
Organon and Co 674
Large-scale testing (Phase 3)Study completedNCT01978496
What this trial is testing

Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine

Who this might be right for
Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1,334
Large-scale testing (Phase 3)Study completedNCT02867709
What this trial is testing

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

Who this might be right for
Migraine, With or Without Aura
Allergan 1,686
Large-scale testing (Phase 3)Study completedNCT03006276
What this trial is testing

Efficacy, Tolerability, and Safety Study of DFN-15

Who this might be right for
Migraine Headache
BioDelivery Sciences International 622
Post-approval studies (Phase 4)Study completedNCT00753311
What this trial is testing

Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.

Who this might be right for
Migraine
IRCCS San Raffaele 80
Large-scale testing (Phase 3)Study completedNCT02848326
What this trial is testing

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Who this might be right for
Migraine, With or Without Aura
Allergan 834
Post-approval studies (Phase 4)Study completedNCT02287376
What this trial is testing

Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds

Who this might be right for
Migraine
Depomed 25
Large-scale testing (Phase 3)Study completedNCT02828020
What this trial is testing

Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine

Who this might be right for
Migraine, With or Without Aura
Allergan 1,672
Not applicableStudy completedNCT03479060
What this trial is testing

Continue or Stop Applying Wet Cupping (Al-Hijamah) in Migraine

Who this might be right for
Migraine DisordersMigraine With AuraMigraine Without Aura
Karabuk University 109
Testing effectiveness (Phase 2)Study completedNCT03962738
What this trial is testing

A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine

Who this might be right for
Migraine
Eli Lilly and Company 846
Testing effectiveness (Phase 2)Study completedNCT03061734
What this trial is testing

Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine

Who this might be right for
Migraine With or Without Aura
Allodynic Therapeutics, Inc 92
Testing effectiveness (Phase 2)Study completedNCT06728553
What this trial is testing

Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults

Who this might be right for
Migraine
Manistee Therapeutics 78
Large-scale testing (Phase 3)Not Yet RecruitingNCT07835152
What this trial is testing

Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults

Who this might be right for
Migraine, With or Without Aura
Brise Pharmaceuticals Co., Ltd. 1,000
Large-scale testing (Phase 3)Study completedNCT00443209
What this trial is testing

Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)

Who this might be right for
Migraine
Merck Sharp & Dohme LLC 1,068
Post-approval studies (Phase 4)Looking for participantsNCT07022496
What this trial is testing

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

Who this might be right for
MigraineMigraine DiseaseMigraine Headache+2 more
Ain Shams University 120
Large-scale testing (Phase 3)Study completedNCT03461757
What this trial is testing

Trial in Adult Subjects With Acute Migraines

Who this might be right for
Migraine, With or Without Aura
Pfizer 1,811
Testing effectiveness (Phase 2)Study completedNCT06245902
What this trial is testing

An Acute Migraine Factorial Study

Who this might be right for
Migraine With or Without Aura
Allodynic Therapeutics, Inc 92
Large-scale testing (Phase 3)Study completedNCT01989936
What this trial is testing

Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan

Who this might be right for
Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 446
Next Page